This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A look at the recent approval of Tarpeyo and a view on commercial potential
Ticker(s): CALTWho's the expert?
Institution: Columbia University
- Professor of Medicine at Columbia University Medical Center and the Clinical Chief of the Nephrology Division at the New York Presbyterian Hospital.
- Currently manages 10 patients with ANCA-Associated Vasculitis and ~40 patients with IgA Nephropathy (IgAN).
- Clinical and research interests are in glomerular diseases and intensive care nephrology; PI for several multicenter studies and has served on DSMBs.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
